|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2010-3-31
|
|
pubmed:abstractText |
Neoadjuvant chemoradiotherapy is considered a standard approach for T3-4 M0 rectal cancer. In this situation, we compared neoadjuvant radiotherapy plus capecitabine with dose-intensified radiotherapy plus capecitabine and oxaliplatin.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BécouarnYvesY,
pubmed-author:BerdahJean-FrançoisJF,
pubmed-author:BouchéOlivierO,
pubmed-author:CoatJ PJP,
pubmed-author:ConroyThierryT,
pubmed-author:DenisBernardB,
pubmed-author:DupuisOlivierO,
pubmed-author:EtiennePierre-LucPL,
pubmed-author:FrançoisEricE,
pubmed-author:GérardJean-PierreJP,
pubmed-author:Gourgou-BourgadeSophieS,
pubmed-author:HennequinChristopheC,
pubmed-author:LledoGérardG,
pubmed-author:MahéMarc AndréMA,
pubmed-author:Martel-LaffayIsabelleI,
pubmed-author:MineurLaurentL,
pubmed-author:MirabelXavierX,
pubmed-author:Montoto-GrillotChristineC,
pubmed-author:VendrelyVéroniqueV,
pubmed-author:de La RocheGuyG
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1638-44
|
|
pubmed:dateRevised |
2011-6-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20194850-Adult,
pubmed-meshheading:20194850-Aged,
pubmed-meshheading:20194850-Aged, 80 and over,
pubmed-meshheading:20194850-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20194850-Chemotherapy, Adjuvant,
pubmed-meshheading:20194850-Combined Modality Therapy,
pubmed-meshheading:20194850-Deoxycytidine,
pubmed-meshheading:20194850-Female,
pubmed-meshheading:20194850-Fluorouracil,
pubmed-meshheading:20194850-Humans,
pubmed-meshheading:20194850-Male,
pubmed-meshheading:20194850-Middle Aged,
pubmed-meshheading:20194850-Neoadjuvant Therapy,
pubmed-meshheading:20194850-Organoplatinum Compounds,
pubmed-meshheading:20194850-Radiotherapy, Adjuvant,
pubmed-meshheading:20194850-Radiotherapy Dosage,
pubmed-meshheading:20194850-Rectal Neoplasms
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.
|
|
pubmed:affiliation |
Centre Antoine Lacassagne, 06189 Nice cedex 2, France. jean-pierre.gerard@cal.nice.fnclcc.fr
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|
